英文原著論文・総説
2024年
1. Ohinata H, Phimarn W, Mizuno M, Obama T, Fukuhara K, Makiyama T, Watanabe
Y, Itabe H. Supressive effect of resveratrol, catwechin and their confomationally
constrained analogs on neutrophil extracellular trap formation by HL-60-derived
neutrophils. J Clin Biol. Med. 2024, 75: 17-23.
2. Watanabe Y, Obama T, Makauiyama T, Itabe H. Oxysterols suppress release
of DNA from granurocytes into extraceellular space after stimulation with
phorbol myristate acetate. Biomedicines, 2024, 12:2535.
2023年
1. Makiyama T, Obama T, Watanabe Y, Chatani M, Azetsu Y, Kawaguchi K, Imanaka
T, Itabe H. Behavior of intracellular lipid droplets during cell division
in HuH7 hepatoma cells, Exp. Cell Res. 2023, 433:113855. doi: 10.1016/j.yexcr.2023.113855
2. Yamamoto M, Sugano M, Itabe H. The etiological consideration of oxidized
low-density lipoprotein in periodontitis. J Oral Biosci. . doi: 1031016/j.job.2022.09.006.
3. Itabe H, Obama T. The oxidized lipoproteins in vio: Its diversity and
behavior in the human circulation. Int J Mol Sci. 2023, 24:5747. doi: 10.3390/ijms24065747.
2022年
1. Makiyama T, Obama , Watanabe Y, Itabe H.: Sar1 affects the localization of perilipin2 to lipid droplets. Int.
J. Mol. Sci. 2022, 23: 6366. doi.10.3390/ijms23126366
2. Ohinata H, Obama T, Makiyama T, Watanabe Y, Itabe H. High-density lipoprotein suppresses neutrophil extracellular traps enhanced by oxidized low-density lipoprotein or oxidized phospholipids. Int J Mol Sci 2022, 23: 13992. doi: 10.3390/ijms232213992..
2021年
1. Itabe H, Sawada N, Makiyama T, Obama T.: Structure and dynamics of oxidized
lipoproteins in vivo: roles of high-density lipoprotein. Biomedicines.
2021, 9: 655. doi.org/10.3390/biomedicines9060655
2. Phimarn W, Bunleu S, Itabe H.: Effects of triphala toimprove lipid profile
and blood glucose and anthropometric parameters. J. Evidence-Based Integr.
Med. 2021, 26. doi.org/10.1177/2515690X211011038.
3. Kato S, Osuka Y, Khalifa S, Obama T, Itabe H, Nakagawa K.: Investigation
of lipoproteins oxidation mechanisms by the analysis of lipid hydroperoxide
isomers. Antioxidants, 2021, 10:1598
2020年
1. Odanaka H, Obama T, Sawada N, Sugano M, Itabe H, Yamamto M.: Comparison of protein profiles of the pellicle, gingival crevicular fluid, and saliva: possible origin of pellicle proteins. Biol. Res. 2020, 53:3.
2. Sawada N, Obama T, Koba S, Takaki T, Iwamoto S, Aiuchi T, Kato R, Kikuchi
M, Hamazaki Y, Itabe H.: Circulating oxidized LDL increased in patients
with acute myocardial infarction is accompanied by heavily modified HDL.
J. Lipid Res. 2020, 61:816-829.
3. Sawada N, Obama T, Mizuno M, Fukuhara K, Iwamoto S, Aiuchi T, Makiyama T, Itabe H.: Transfer and enzyme-mediated metabolism of oxidized phosphatidylcholine and lysophosphatidylcholine between low- and hihg-density lipoproteins. Antioxidants, 2020, 9:E1045.
4. Shimamura H, Katsuragi S, Yoshikawa M, Nakura M, Sasaki T, Itabe H.:
Standard pharmacist intervention checklist to improve the appropriateness
use of medications for inpatients with polypharmacy. BPB Rep. 2020, 3:196-201.
2019年
1. Kato R, Hayashi M, Aiuchi T, Sawada N, Obama T, Itabe H.: Temporal and
spatial changes of peroxiredoxin 2 levels in aortic media at very early
stages of atheroslcerotic lesion formation in apE-knockout mice. Free Rad.
Biol. Med. 2019, 130:348-360.
2. Itabe H, Kato R, Sasabe S, Obama T, Yamamoto M.: Significance of oxidized
low-density lipoprotein in body fluids as a marker related to diseased
conditions. Curr. Med. Chem. 2019, vol.26: 1576-1593. (review)
3. Obama T, Miyazaki T, Aiuchi T, Miyazaki A, Itabe H.: Evaluation pf protein-protein
interactions using an on-membrane digestion technique. JoVE, 2019, 149:e59733.
4. Obama T, Ohinata H, Takaki T, Iwamoto S, Sawada N, Aiuchi T, Kato R,
Itabe H.: Cooperative action of oxidized low-density lipoproteins and neutrophils
on endothelial inflammatory responses through neutrophil extracellular
trap formation. Frontiers in Immunology, 2019, 10:1899.
5. Kawata N. Kang D, Aiuchi T, Obama T, Shibata T, Murakami M, Takimoto
M, Itabe H, Honda K. Proteomics of human glomerulonephritis by laser microdisection
and liquid-chromatography-tandem mass spectrometry. Nephrology, 2019, 25:351-359.
6. Uekita H, Ishibashi T, Shiomi M, Koyama H, Ohtsuka S, Yamamoto H, Yamagishi
S, Inoue H, Itabe H, Sugimoto K, Kamioka M, Ohkawara H, Wada I, Yasuchika
T.: Integral role of receptor for advanced glycation end products (RAGE)
in nondiabetic atherosclerosis. Fukushima J. Med. Sci. 2019, 65:109-121.
7. Takemaru M, Sawada N, Aiuchi T, Itabe H, Yamamoto M.: Comparison of
protei profiles of gingival crevicular fluids collected from incisiors,
canines and molars. Showa Univ. J. Med. Sci. 2019, 31:365-372.
2018年
1. Kuwata H, Yuzurihara C, Kinoshita N, Taki Y, Ikegami Y, Washio S, Hirakawa
Y, Yoda E, Aiuchi T, Itabe H, Nakatani Y, Hara S.: The group VIA calcium-independent
phospholipase A2 and NFATc4 pathway mediates IL-1β-induced expression of
chemokines CCL2 and CXCL10 in rat fibroblasts. FEBS J. 2018;285(11):2056-2070.
2. Shimamura H, Yamada H, Okada N, Uchikura T, Tanaka K, Sasaki T, Itabe
H.: A standard intervention practice to promote appropriate lamotrigine
therapy by pharmacists. Biol. Pharm. Bull. 2018, 41(4) 465-469.
3. Ning B, Chen Y, Waqar AB, Yan H, Shiomi M, Zhang J, Chen YE, Wang Y,
Itabe H, Liang J, Fan J.: Hypertension enhances advanced atherosclerosis
and induces cardiac death in Watanabe heritable hyperlipidemic rabbits.
Am. J. Pathol. 2018, 188(12):2936-2947.
2017年
1. Ishizuka M, Kato R, Moriya Y, Noguchi E, Koide Y, Inoue S, Itabe H,
Yamamoto M.: Changes in apolipoprotein B and oxidized low-density lipoprotein
levels in gingival crevicular fluids caused by periodontal tissue conditions.
J. Periodont. Res. 2017, 52:594-602.
2. Moriya Y, Obama T, Aiuchi T, Sugiyama T, Endo Y, Koide Y, Noguchi E,
Ishizuka M, Inoue M, Itabe H, Yamamoto M.: Quantitative proteomic analysis
of gingival crevicular fluids from deciduous and permanent teeth. J. Clin.
Periodontol. 2017, 44:353-362.
3. Yamada S, Koike T, Nakagawa T, Kuniyoshi N, Ying Y, Itabe H, Yamashita
A, Asada Y, Shiomi M.: Morphological features of coronary plaques in WHHLMI
rabbits (Oryctolagus cuniculus), An animal model for familial hypercholesterolemia.
Experimental Animals, 2017, 66:145-157.
4. Forrester SJ, Elliott KJ, Kawai T, Obama T, Boyer MJ, Preston KJ, Yan
Z, Eguchi S, Rizzo V.: Caveolin-1 Deletion Prevents Hypertensive Vascular
Remodeling Induced by Angiotensin II. Hypertension. 2017, 69:79-86.
5. Itabe H, Yamaguchi T, Nimura S, asabe N.: Perilipins: A diversity of
intracellular lipid droplet proteins. Lipids Health Dis. 2017, 16:83. (review)
2016年
1. Kurosawa T, Yamada A, Suzuki D, Morimura N, Sasagane Y, Itabe H, Kamijo R. Nephronectin expression is up-regulated by BMP-2. Biol. Pharm. Bull., 2016, 39:1211-1215. doi: 10.1248/bpb.b15-00941.
2. Miyazaki T, Tonami K, Hata S, Aiuchi T, Ohnishi K, Lei X-F, Kim-Kaneyama J, Takeya M, Itabe, H, Sorimachi H, Kurihara H, Miyazaki A.: Disturbance of pre-mRNA splicing by calpain-6 aggravates pinocytotic cholesterol deposition in macrophages. J. Clin. Invest. 2016, 126:3417-3432. doi: 10.1172/JCI85880.
2015年
1. Arita-Okubo S, Kim-Kaneyama JR, Lei XF, Fu WG, Ohnishi K, Takeya M, Miyauchi
A, Honda H, Itabe H, Miyazaki T, Miyazaki A.: Role of Hic-5 in the formation
of microvilli-like structures and the monocyte-endothelial interaction
that accelerates atherosclerosis. Cardiovasc. Res. 2015, 105:361-371. doi:
10.1093/cvr/cvv003.
2.Tamaki Kurosawa, Atsushi Yamada, Masamichi Takami,Dai Suzuki, Yoshiro Saito,
Katsuhiro Hiranuma, Takuya Enomoto, Naoko Morimura, Matsuo Yamamoto, Takehiko
Iijima, Tatsuo Shirota, Hiroyuki Itabe, Ryutaro Kamijo. Expression of Nephronectin
is inhibited by Oncostatin M via both JAK/STAT and MAPK pathways. FEBS
Open Bio. 2015, 5:303-307. doi10.1016/j.fob.2015.04.001.
3.Yuka Keyamura, Chifumi Nagano, Masayuki Kohashi, Manabu Niimi, Masanori
Nozako, Takashi Koyama, Hiroyuki Itabe, Tomohiro Yoshikawa.: Dietary-cholesterol
atherogenesis drastically changed during the juvenile period in rabbits.
Biol. Pharm. Bull. 2015, 38:785-788..doi. 10.1016/j.fob.2015.04.001.
4. Takayanagi T, Kawai T, Forrester SJ, Obama T, Tsuji T, Fukuda Y, Elliott
KJ, Tilley DG, Davisson RL, Park JY, Eguchi S. Role of Epidermal Growth
Factor Receptor and Endoplasmic Reticulum Stress in Vascular Remodeling
Induced by Angiotensin II. Hypertension. 2015 65:1349-1355. doi: 10.1161/HYPERTENSIONAHA.115.05344.
5. Obama T, Tsuji T, Kobayashi T, Fukuda Y, Takayanagi T, Taro Y, Kawai T,
Forrester SJ, Elliott KJ, Choi E, Daugherty A, Rizzo V, Eguchi S. Epidermal
growth factor receptor inhibitor protects against abdominal aortic aneurysm
in a mouse model. Clin Sci (Lond). 2015, 128:559-565. doi: 10.1042/CS20140696.
6. Tomohiro Yamaguchi, Noriyuki Fujikawa, Satomi Nimura, Yutaro Tokuoka, Sonoka
Tsuda, Toshihiro Aiuchi, Rina Kato, Takashi Obama, Hiroyuki Itabe. Characterization
of lipid droplets in steroidogenic MLTC-1 Leydig cells: Protein profiles
and the morphological change induced by hormone stimulation. BBA - Molecular
and Cell Biology of Lipids, 2015, 1851:1285-1295. doi:10.1016/j.bbalip.2015.06.007.
7.Satomi Nimura, Tomohiro Yamaguchi, Koki Ueda, Karin Kadokura, Toshihiro
Aiuchi, Rina Kato, Takashi Obama, Hiroyuki Itabe. Olanzapine promotes the
accumulation of lipid droplets and the expression of multiple perilipins
in human adipocytes. Biochem. Biophys. Res. Commun. 2015, 467: 906-912. doi:10.1016/j.bbrc.2015.10.045
和文総説・著書
1. 小濱孝士、板部洋之: 血管炎症誘導における酸化変性リポタンパク質と好中球細胞外トラップ形成の相乗作用 (特集 動脈硬化とNETs) MSD メディカル・サイエンス・ダイジェスト (2022) 48:300-302
2. 板部洋之: 動脈硬化の発症・進展に関わる酸化変性リポタンパク質 昭和大学学士会雑誌 (2021)
81:370-9
3. 板部洋之、小濵孝士ら:「詳解 生化学」(板部、荒田 編著) 京都廣川書店 (2021)
4. 小濵孝士、板部洋之: 動脈硬化とNETs:酸化LDLとの相乗作用 Thrombosis Medicine (2019) 9:285-291
5. 笹部直子、板部洋之: Lp-PLA2と変性リポタンパク質の代謝 臨床化学 (2018) 7巻2号128-135
6. 板部洋之ら:構造式手帳第2版 (伊藤喬編著)(2016) 京都廣川書店、東京
7.「生物系薬学Ⅱ.生体防御と微生物」(スタンダード薬学シリーズⅡ4、高橋悟、野口雅久、山元弘、板部洋之、有賀寛芳、奥直人 編) (2016) 東京化学同人、東京
8. 小浜孝士、板部洋之: 生体内酸化LDL中のバイオマーカー網羅的探索 昭和学士会雑誌(2015)75:138-146
9.「カラー生化学 第4版」 マシューズ、ヴァン・ホルダ、アプリング、アンソニー・ケイヒル
(石浦章一、板部洋之、高木正道、中谷一泰、水島昇、横溝岳彦 監訳)(2015) 西村書店、東京